The Antibiotics Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
The global antibiotics market is anticipated to grow owing to the rise in the prevalence of infectious diseases. In addition, the demand is being fuelled by the emergence of innovative methods for new antibiotics for treating bacterial infections, as well as a large number of clinical trials. However, the industry is expected to be hampered by the rise of antibiotic resistance, which is fuelled by antibiotic abuse, as well as the time it takes for regulatory approval. On the other hand, market players across the value chain should expect major profit potential from the development of advanced prospect molecules & novel combination therapies to treat antibiotic-resistant microbial (AMR) infections.
What Questions Should You Ask before Buying a Market Research Report?
• How is the antibiotics market evolving?
• What is driving and restraining the antibiotics market?
• How will each antibiotics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each antibiotics submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading antibiotics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the antibiotics projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
antibiotics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the antibiotics market?
• Where is the antibiotics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the antibiotics market today, and over the next 10 years:
• Our 388-page report provides 144 tables and 223 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the antibiotics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Action Mechanism
• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Others
Drug Class
• Cephalosporin
• Penicillin
• Fluoroquinolone
• Macrolide
• Carbapenem
• Aminoglycoside
• Sulfonamide
• 7-ACA
• Others
Gender
• Male
• Female
Age Group
• 0-14 years
• 15-54 years
• 55 years and over
Route of Administration
• Oral
• Intravenous
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 30 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Denmark
• Norway
• Sweden
• Finland
• Netherlands
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• Australia
• Singapore
• Malaysia
• Sri Lanka
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Antibiotics Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Abbott Laboratories
• Allergan (AbbVie Inc.)
• Amneal Pharmaceuticals LLC
• Cipla Ltd.
• Cumberland Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd.
• GSK plc
• Lupin
• Melinta Therapeutics LLC
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Viatris, Inc.
• WOCKHARDT
Overall world revenue for Antibiotics Market, 2023 to 2033 in terms of value the market will surpass US$46,575 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Antibiotics Market, 2023 to 2033 report help you?
In summary, our 380+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Antibiotics Market, 2023 to 2033 Market, with forecasts for Action Mechanism, Drug Class, Gender, Age Group, and Route of Administration, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 30 key national markets – See forecasts for the Antibiotics Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the Antibiotics Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Antibiotics Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Antibiotics Market Report 2023-2033: Forecasts by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA, Others), by Gender (Male, Female), by Age Group (0-14 Years, 15-54 Years, 55 Years and Over), by Route of Administration (Oral, Intravenous, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Antibiotics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Market Drivers
3.3.1 Growing Burden of Infectious Diseases to Fuel Market Growth
3.3.2 Adoption of Digital Health Technology to Boost Antibiotics Market Growth
3.3.3 Rising Ageing Population Patient Pool to Drive Growth
3.4 Market Restraints
3.4.1 Strict Regulatory Scenarios to Hamper Market Growth
3.4.2 Rising Antibiotic Resistance to Restrain Market Growth
3.5 Market Opportunities
3.6 SWOT Analysis
3.6.1 Strengths of Antibiotics Market
3.6.2 Weaknesses of Antibiotics Market
3.6.3 Opportunities in Antibiotics Market
3.6.4 Threats in Antibiotics Market
3.7 Industry analysis - Porter’s
3.7.1 Bargaining Power of Buyers (Low)
3.7.2 Bargaining Power of Suppliers (Low)
3.7.3 Intensity of Competitive Rivalry (High)
3.7.4 Threat of Substitute (Low)
3.7.5 Threat of New Entrants (Low)
3.8 PEST Analysis
3.8.1 Political Factors Impacting Antibiotics Market
3.8.1.1 Government Scenario
3.8.1.2 Closed Market
3.8.1.3 Price Control
3.8.2 Economic Factors Impacting Antibiotics Market
3.8.2.1 Growth in Individual Income
3.8.2.2 New Drugs
3.8.2.3 Cost Cutting
3.8.3 Social Factors Impacting Antibiotics Market
3.8.3.1 Generation Health
3.8.3.2 Infectious Diseases
3.8.3.3 Health Consciousness
3.8.4 Technological Factors Impacting Antibiotics Market
3.8.4.1 Biotech Industry Growth
3.8.4.2 Market Penetration
3.9 COVID-19 Impact Analysis
4 Antibiotics Market Analysis by Action Mechanism
4.1 Key Findings
4.2 Action Mechanism Segment: Market Attractiveness Index
4.3 Antibiotics Market Size Estimation and Forecast by Action Mechanism
4.4 Cell Wall Synthesis Inhibitors
4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Protein Synthesis Inhibitors
4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 DNA Synthesis Inhibitors
4.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 RNA Synthesis Inhibitors
4.7.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Mycolic Acid Inhibitors
4.8.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Others
4.9.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.9.2 Market Share by Region, 2023 & 2033 (%)
5 Antibiotics Market Analysis by Drug Class
5.1 Key Findings
5.2 Drug Class Segment: Market Attractiveness Index
5.3 Antibiotics Market Size Estimation and Forecast by Drug Class
5.4 Cephalosporin
5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Penicillin
5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Fluoroquinolone
5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Macrolide
5.7.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Carbapenem
5.8.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Aminoglycoside
5.9.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.9.2 Market Share by Region, 2023 & 2033 (%)
5.10 Sulfonamide
5.10.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.10.2 Market Share by Region, 2023 & 2033 (%)
5.11 7-ACA
5.11.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.11.2 Market Share by Region, 2023 & 2033 (%)
5.12 Others
5.12.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.12.2 Market Share by Region, 2023 & 2033 (%)
6 Antibiotics Market Analysis by Gender
6.1 Key Findings
6.2 Gender Segment: Market Attractiveness Index
6.3 Antibiotics Market Size Estimation and Forecast by Gender
6.4 Male
6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Female
6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
7 Antibiotics Market Analysis by Age Group
7.1 Key Findings
7.2 Age Group Segment: Market Attractiveness Index
7.3 Antibiotics Market Size Estimation and Forecast by Age Group
7.4 0-14 Years
7.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 15-54 Years
7.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 55 Years and Over
7.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
7.6.2 Market Share by Region, 2023 & 2033 (%)
8 Antibiotics Market Analysis by Route of Administration
8.1 Key Findings
8.2 Route of Administration Segment: Market Attractiveness Index
8.3 Antibiotics Market Size Estimation and Forecast by Route of Administration
8.4 Oral
8.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
8.4.2 Market Share by Region, 2023 & 2033 (%)
8.5 Intravenous
8.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
8.5.2 Market Share by Region, 2023 & 2033 (%)
8.6 Others
8.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
8.6.2 Market Share by Region, 2023 & 2033 (%)
9 Antibiotics Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
10 North America Antibiotics Market Analysis
10.1 Key Findings
10.2 North America Antibiotics Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
10.5 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
10.6 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
10.7 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
10.8 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
10.9 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
10.10 U.S. Antibiotics Market Analysis
10.11 Canada Antibiotics Market Analysis
11 Europe Antibiotics Market Analysis
11.1 Key Findings
11.2 Europe Antibiotics Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
11.5 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
11.6 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
11.7 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
11.8 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
11.9 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
11.10 Germany Antibiotics Market Analysis
11.11 UK Antibiotics Market Analysis
11.12 France Antibiotics Market Analysis
11.13 Italy Antibiotics Market Analysis
11.14 Spain Antibiotics Market Analysis
11.15 Russia Antibiotics Market Analysis
11.16 Denmark Antibiotics Market Analysis
11.17 Norway Antibiotics Market Analysis
11.18 Sweden Antibiotics Market Analysis
11.19 Finland Antibiotics Market Analysis
11.20 Netherlands Antibiotics Market Analysis
11.21 Rest of Europe Antibiotics Market Analysis
12 Asia Pacific Antibiotics Market Analysis
12.1 Key Findings
12.2 Asia Pacific Antibiotics Market Attractiveness Index
12.3 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
12.4 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
12.5 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
12.6 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
12.7 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
12.8 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
12.9 Japan Antibiotics Market Analysis
12.10 China Antibiotics Market Analysis
12.11 India Antibiotics Market Analysis
12.12 Australia Antibiotics Market Analysis
12.13 Singapore Antibiotics Market Analysis
12.14 Malaysia Antibiotics Market Analysis
12.15 Sri Lanka Antibiotics Market Analysis
12.16 Rest of Asia Pacific Antibiotics Market Analysis
13 Latin America Antibiotics Market Analysis
13.1 Key Findings
13.2 Latin America Antibiotics Market Attractiveness Index
13.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
13.5 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
13.6 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
13.7 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
13.8 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
13.9 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
13.10 Brazil Antibiotics Market Analysis
13.11 Mexico Antibiotics Market Analysis
13.12 Argentina Antibiotics Market Analysis
13.13 Colombia Antibiotics Market Analysis
13.14 Rest of Latin America Antibiotics Market Analysis
14 MEA Antibiotics Market Analysis
14.1 Key Findings
14.2 MEA Antibiotics Market Attractiveness Index
14.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
14.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
14.5 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
14.6 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
14.7 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
14.8 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
14.9 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
14.10 GCC Antibiotics Market Analysis
14.11 South Africa Antibiotics Market Analysis
14.12 Rest of MEA Antibiotics Market Analysis
15 Company Profiles
15.1 Antibiotics Market: Company Wise Ranking
15.2 Key Strategies Followed by Leading Antibiotics Players
15.2.1 Internationalization
15.2.2 Product Range Breadth
15.2.3 Capability Development
15.2.4 Cost Differentiation
15.2.5 Vertical Integration
15.3 Pipeline Analysis
15.4 Abbott Laboratories
15.4.1 Company Snapshot
15.4.2 Abbott Laboratories Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2015-2021
15.4.3.2 R&D Expenses, 2015-2021
15.4.3.3 Gross Profit, 2015-2021
15.4.3.4 Regional Market Share, 2021
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 F. Hoffmann-La Roche Ltd.
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2015-2021
15.5.3.2 R&D Expenses, 2015-2021
15.5.3.3 Gross Profit, 2015-2021
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 GSK plc
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2015-2021
15.6.3.2 R&D Expenses, 2015-2021
15.6.3.3 Gross Profit, 2015-2021
15.6.3.4 Regional Market Share, 2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Merck & Co. Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2015-2021
15.7.3.2 R&D Expenses, 2015-2021
15.7.3.3 Gross Profit, 2015-2021
15.7.3.4 Regional Market Share, 2021
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Viatris, Inc. (Mylan)
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2015-2021
15.8.3.2 R&D Expenses, 2015-2021
15.8.3.3 Gross Profit, 2015-2021
15.8.3.4 Regional Market Share, 2021
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Novartis AG
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2015-2021
15.9.3.2 R&D Expenses, 2015-2021
15.9.3.3 Gross Profit, 2015-2021
15.9.3.4 Regional Market Share
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Pfizer Inc.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2015-2021
15.10.3.2 R&D Expenses, 2015-2021
15.10.3.3 Gross Profit, 2015-2021
15.10.3.4 Regional Market Share, 2021
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Sanofi
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2015-2021
15.11.3.2 R&D Expenses, 2015-2021
15.11.3.3 Gross Profit, 2015-2021
15.11.3.4 Regional Market Share, 2021
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Teva Pharmaceutical Industries Ltd.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2015-2021
15.12.3.2 R&D Expenses, 2015-2021
15.12.3.3 Gross Profit, 2015-2021
15.12.3.4 Regional Market Share, 2021
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Cipla Ltd.
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2015-2021
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Allergan (AbbVie Inc.)
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue, 2015-2021
15.14.3.2 R&D Expenses, 2015-2021
15.14.3.3 Gross Profit, 2015-2021
15.14.3.4 Regional Market Share, 2021
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook
15.15 Cumberland Pharmaceuticals, Inc.
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2015-2021
15.15.3.2 R&D Expenses, 2015-2021
15.15.3.3 Gross Profit, 2015-2021
15.15.4 Product Benchmarking
15.15.5 Strategic Outlook
15.16 Lupin
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Product Benchmarking
15.16.4 Strategic Outlook
15.17 Melinta Therapeutics LLC
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Product Benchmarking
15.17.4 Strategic Outlook
15.18 Amneal Pharmaceuticals LLC
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2015-2021
15.18.3.2 R&D Expenses, 2015-2021
15.18.3.3 Gross Profit, 2015-2021
15.18.4 Product Benchmarking
15.18.5 Strategic Outlook
15.19 WOCKHARDT
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Product Benchmarking
15.19.4 Strategic Outlook
16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players
List of Tables
Table 1 Antibiotics Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 7 Cell Wall Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 8 Protein Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 9 DNA Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 10 RNA Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 11 Mycolic Acid Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 12 Others Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 13 Global Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 14 Cephalosporin Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 15 Penicillin Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 16 Fluoroquinolone Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 17 Macrolide Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 18 Carbapenem Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 19 Aminoglycoside Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 20 Sulfonamide Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 21 7-ACA Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 23 Global Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 24 Male Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 25 Female Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 26 Global Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 27 0-14 Years Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 28 15-54 Years Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 29 55 Years and Over Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 30 Global Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 31 Oral Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 32 Intravenous Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 33 Others Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 34 Global Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%)
Table 35 North America Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 36 North America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 37 North America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 38 North America Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 39 North America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 40 North America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 41 U.S. Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 42 Canada Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 43 Europe Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 44 Europe Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 45 Europe Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 46 Europe Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 47 Europe Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 48 Europe Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 49 Germany Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 50 UK Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 51 France Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 52 Italy Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 53 Spain Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 54 Russia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 55 Denmark Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 56 Norway Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 57 Sweden Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 58 Finland Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 59 Netherlands Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 60 Rest of Europe Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 61 APAC Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 62 APAC Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 63 APAC Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 64 APAC Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 65 APAC Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 66 APAC Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 67 Japan Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 68 China Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 69 India Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 70 Australia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 71 Singapore Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 72 Malaysia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 73 Sri Lanka Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 74 Rest of APAC Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 75 Latin America Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 76 Latin America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 77 Latin America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 78 Latin America Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 79 Latin America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 80 Latin America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 81 Brazil Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 82 Mexico Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 83 Argentina Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 84 Colombia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 85 Rest of LATAM Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 86 MEA Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 87 MEA Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 88 MEA Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 89 MEA Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 90 MEA Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 91 MEA Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 92 GCC Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 93 South Africa Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 94 Rest of MEA Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 95 Antibiotics Market: Company Ranking
Table 96 Antibiotics Pipeline Analysis
Table 97 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Abbott Laboratories: Product Benchmarking
Table 99 Abbott.: Strategic Outlook
Table 100 Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 102 F. Hoffmann-La Roche Ltd.: Strategic Outlook
Table 103 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 GSK plc: Product Benchmarking
Table 105 GSK plc: Strategic Outlook
Table 106 Merck & Co. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Merck & Co. Inc.: Product Benchmarking
Table 108 Merck & Co. Inc.: Strategic Outlook
Table 109 Viatris, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Viatris, Inc.: Product Benchmarking
Table 111 Viatris, Inc.: Strategic Outlook
Table 112 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Novartis AG: Product Benchmarking
Table 114 Novartis AG: Strategic Outlook
Table 115 Pfizer Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Pfizer Inc: Product Benchmarking
Table 117 Pfizer Inc: Strategic Outlook
Table 118 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Sanofi: Product Benchmarking
Table 120 Sanofi.: Strategic Outlook
Table 121 Teva Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Teva Pharmaceutical Industries Ltd: Product Benchmarking
Table 123 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 124 Cipla Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Cipla Ltd: Product Benchmarking
Table 126 Cipla Ltd: Strategic Outlook
Table 127 Allergan (AbbVie Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Allergan (AbbVie Inc.): Product Benchmarking
Table 129 Allergan (AbbVie Inc.): Strategic Outlook
Table 130 Cumberland Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 Cumberland Pharmaceuticals, Inc.: Product Benchmarking
Table 132 Cumberland Pharmaceuticals, Inc.: Strategic Outlook
Table 133 Lupin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Lupin: Product Benchmarking
Table 135 Lupin: Strategic Outlook
Table 136 Melinta Therapeutics LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Melinta Therapeutics LLC: Product Benchmarking
Table 138 Melinta Therapeutics LLC: Strategic Outlook
Table 139 Amneal Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Amneal Pharmaceuticals LLC: Product Benchmarking
Table 141 Amneal Pharmaceuticals LLC: Strategic Outlook
Table 142 WOCKHARDT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 WOCKHARDT: Product Benchmarking
Table 144 WOCKHARDT: Strategic Outlook
List of Figures
Figure 1 Antibiotics Market Segmentation
Figure 2 Antibiotics Market by Action Mechanism: Market Attractiveness Index
Figure 3 Antibiotics Market by Drug Class: Market Attractiveness Index
Figure 4 Antibiotics Market by Gender: Market Attractiveness Index
Figure 5 Antibiotics Market by Age Group: Market Attractiveness Index
Figure 6 Antibiotics Market by Route of Administration: Market Attractiveness Index
Figure 7 Antibiotics Market: Market Trends
Figure 8 Antibiotics Market: SWOT Analysis
Figure 9 Porter’s Analysis
Figure 10 PEST Analysis
Figure 11 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 12 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 13 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 14 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 15 Antibiotics Market Attractiveness Index by Action Mechanism
Figure 16 Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million)
Figure 17 Antibiotics Market Share Forecast by Action Mechanism, 2023, 2028, 2033 (%)
Figure 18 Cell Wall Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 19 Cell Wall Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Protein Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 21 Protein Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 DNA Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 23 DNA Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 RNA Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 25 RNA Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Mycolic Acid Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 27 Mycolic Acid Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 29 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Antibiotics Market Attractiveness Index by Action Mechanism
Figure 31 Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million)
Figure 32 Antibiotics Market Share Forecast by Drug Class, 2023, 2028, 2033 (%)
Figure 33 Cephalosporin Market Forecast by Region, 2023-2033 (US$ million)
Figure 34 Cephalosporin Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Penicillin Market Forecast by Region, 2023-2033 (US$ million)
Figure 36 Penicillin Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Fluoroquinolone Market Forecast by Region, 2023-2033 (US$ million)
Figure 38 Fluoroquinolone Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Macrolide Market Forecast by Region, 2023-2033 (US$ million)
Figure 40 Macrolide Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Carbapenem Market Forecast by Region, 2023-2033 (US$ million)
Figure 42 Carbapenem Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Aminoglycoside Market Forecast by Region, 2023-2033 (US$ million)
Figure 44 Aminoglycoside Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Sulfonamide Market Forecast by Region, 2023-2033 (US$ million)
Figure 46 Sulfonamide Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 7-ACA Market Forecast by Region, 2023-2033 (US$ million)
Figure 48 7-ACA Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 50 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Antibiotics Market Attractiveness Index by Gender
Figure 52 Antibiotics Market Forecast by Gender, 2023-2033 (US$ million)
Figure 53 Antibiotics Market Share Forecast by Gender, 2023, 2028, 2033 (%)
Figure 54 Male Market Forecast by Region, 2023-2033 (US$ million)
Figure 55 Male Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Female Market Forecast by Region, 2023-2033 (US$ million)
Figure 57 Female Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Antibiotics Market Attractiveness Index by Age Group
Figure 59 Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million)
Figure 60 Antibiotics Market Share Forecast by Age Group, 2023, 2028, 2033 (%)
Figure 61 0-14 Market Forecast by Region, 2023-2033 (US$ million)
Figure 62 0-14 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 15-54 Market Forecast by Region, 2023-2033 (US$ million)
Figure 64 15-54 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 55 years and over Market Forecast by Region, 2023-2033 (US$ million)
Figure 66 55 years and over Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Antibiotics Market Attractiveness Index by Route of Administration
Figure 68 Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 69 Antibiotics Market Share Forecast by Route of Administration, 2023, 2028, 2033 (%)
Figure 70 Oral Market Forecast by Region, 2023-2033 (US$ million)
Figure 71 Oral Market Share Forecast by Region, 2023 & 2033 (%)
Figure 72 Intravenous Market Forecast by Region, 2023-2033 (US$ million)
Figure 73 Intravenous Market Share Forecast by Region, 2023 & 2033 (%)
Figure 74 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 75 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 76 Antibiotics Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 77 Antibiotics Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 78 Antibiotics Market by Region, 2023-2033 (US$ Mn)
Figure 79 North America Antibiotics Market Attractiveness Index
Figure 80 North America Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 81 North America Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 82 North America Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 83 North America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 84 North America Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 85 North America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 86 North America Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 87 North America Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 88 North America Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 89 North America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 90 North America Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 91 North America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 92 North America Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 93 U.S. Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 94 Canada Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 95 Europe Antibiotics Market Attractiveness Index
Figure 96 Europe Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 97 Europe Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 98 Europe Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 99 Europe Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 100 Europe Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 101 Europe Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 102 Europe Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 103 Europe Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 104 Europe Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 105 Europe Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 106 Europe Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 107 Europe Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 108 Europe Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 109 Germany Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 110 UK Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 111 France Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 112 Italy Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 113 Spain Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 114 Russia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 115 Denmark Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 116 Norway Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 117 Sweden Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 118 Finland Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 119 Netherlands Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 120 Rest of Europe Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 121 Asia Pacific Antibiotics Market Attractiveness Index
Figure 122 Asia Pacific Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 123 Asia Pacific Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 124 Asia Pacific Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 125 Asia Pacific Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 126 Asia Pacific Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 127 Asia Pacific Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 128 Asia Pacific Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 129 Asia Pacific Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 130 Asia Pacific Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 131 Asia Pacific Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 132 Asia Pacific Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 133 Asia Pacific Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 134 Japan Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 135 China Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 136 India Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 137 Australia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 138 Singapore Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 139 Malaysia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 140 Sri Lanka Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 141 Rest of Asia Pacific Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 142 Latin America Antibiotics Market Attractiveness Index
Figure 143 Latin America Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 144 Latin America Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 145 Latin America Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 146 Latin America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 147 Latin America Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 148 Latin America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 149 Latin America Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 150 Latin America Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 151 Latin America Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 152 Latin America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 153 Latin America Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 154 Latin America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 155 Latin America Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 156 Brazil Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 157 Mexico Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 158 Argentina Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 159 Colombia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 160 Rest of Latin America Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 161 MEA Antibiotics Market Attractiveness Index
Figure 162 MEA Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 163 MEA Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 164 MEA Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 165 MEA Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 166 MEA Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 167 MEA Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 168 MEA Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 169 MEA Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 170 MEA Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 171 MEA Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 172 MEA Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 173 MEA Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 174 MEA Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 175 GCC Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 176 South Africa Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 177 Rest of MEA Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 178 Abbott Laboratories: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 179 Abbott Laboratories: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 180 Abbott Laboratories: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 181 Abbott Laboratories: Regional Market Share, 2021
Figure 182 Hoffmann-La Roche Ltd.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 183 F. Hoffmann-La Roche Ltd.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 184 F. Hoffmann-La Roche Ltd.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 185 GSK plc: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 186 GSK plc: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 187 GSK plc: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 188 GSK plc: Regional Market Share, 2021
Figure 189 Merck & Co. Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 190 Merck & Co. Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 191 Merck & Co. Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 192 Merck & Co. Inc.: Regional Market Share, 2021
Figure 193 Viatris, Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 194 Viatris, Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 195 Viatris, Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 196 Viatris, Inc.: Regional Market Share, 2021
Figure 197 Novartis AG: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 198 Novartis AG: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 199 Novartis AG: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 200 Novartis AG: Regional Market Share, 2021
Figure 201 Pfizer Inc: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 202 Pfizer Inc: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 203 Pfizer Inc: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 204 Pfizer Inc: Regional Market Share, 2021
Figure 205 Sanofi: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 206 Sanofi: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 207 Sanofi: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 208 Sanofi: Regional Market Share, 2021
Figure 209 Teva Pharmaceutical Industries Ltd: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 210 Teva Pharmaceutical Industries Ltd: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 211 Teva Pharmaceutical Industries Ltd: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 212 Teva Pharmaceutical Industries Ltd: Regional Market Share, 2021
Figure 213 Cipla Ltd: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 214 Allergan (AbbVie Inc.): Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 215 Allergan (AbbVie Inc.): R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 216 Allergan (AbbVie Inc.): Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 217 Allergan (AbbVie Inc.): Regional Market Share, 2021
Figure 218 Cumberland Pharmaceuticals, Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 219 Cumberland Pharmaceuticals, Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 220 Cumberland Pharmaceuticals, Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 221 Amneal Pharmaceuticals LLC: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 222 Amneal Pharmaceuticals LLC: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 223 Amneal Pharmaceuticals LLC: Gross Profit, 2015-2021 (US$ million, AGR%)
List of Companies Profiled in the Report
Abbott Laboratories
Allergan (AbbVie Inc.)
Amneal Pharmaceuticals LLC
Cipla Ltd.
Cumberland Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
GSK plc
Lupin
Melinta Therapeutics LLC
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
Viatris, Inc.
WOCKHARDT
List of Other Companies Mentioned in the Report
Acurx Pharmaceuticals, Inc.
ADVANZ PHARMA Corp. Limited
Alfresa Pharma Corporation
Amplyx Pharmaceuticals
BD
Centrient Pharmaceuticals
Cidara Therapeutics
Daiichi Sankyo Company, Limited
Dr. Reddy's Laboratories Ltd.
Evonik
Hikma Pharmaceuticals PLC
Jiangxi Jemincare Group Company
Kiora Pharmaceuticals, Inc.
Medochemie
Mutabilis
Nosopharm
NovoBiotic Pharmaceuticals, LLC
Olgram SAS
Paratek Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc.
Sandoz
Shionogi & Co., Ltd.
Sistema Group
Spero Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd
Sumitovant Biopharma Ltd.
Tabuk Pharmaceutical Manufacturing Company
Venatorx Pharmaceuticals, Inc.
List of Associations Mentioned in the Report
Alliance for the Prudent Use of Antibiotics
American Medical Association
Antibiotic Research UK
BEAM (Biotech companies in Europe combating Anti-Microbial Resistance) Alliance
Centers for Disease Control and Prevention
European Centre for Disease Prevention and Control (ECDC)
European Medicines Agency (EMA)
Food and Drug Administration (FDA)
Global Antibiotic Research & Development Partnership (GARDP)
Global Antimicrobial Resistance Surveillance System (GLASS)
Infectious Diseases Society of America
International Society of Antimicrobial Chemotherapy
Journal of Medical Society
Microbiology Society
National Institute for Health and Clinical Excellence (NICE)
National Institutes of Health (NIH)
Society of Hospital Medicine
The British Society for Antimicrobial Chemotherapy (BSAC)
The Infectious Diseases Society of America (IDSA)
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
